We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01000558
First Posted: October 23, 2009
Last Update Posted: May 20, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group
October 22, 2009
October 23, 2009
May 20, 2013
March 2005
July 2011   (Final data collection date for primary outcome measure)
Establishment of a Centralized Lymphoma Serum Repository for the Southwest Oncology Group [ Time Frame: July 2011 ]
  • Establishment of a Centralized Lymphoma Serum Repository for the Southwest Oncology Group
  • Provide a unique database resource for clinicopathologic correlations with the results of any serum assay
Complete list of historical versions of study NCT01000558 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol

RATIONALE: Collecting and storing samples of blood from patients with cancer to test in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing blood samples from patients with previously untreated non-Hodgkin lymphoma.

OBJECTIVES:

  • To establish a central lymphoma serum repository that will serve as a resource to provide specimens for current and future scientific studies.
  • To utilize the Southwest Oncology Group clinical database to perform clinicopathologic correlations with the results of those studies.

OUTLINE: Serum is collected and stored for future correlative studies.

Observational
Not Provided
Not Provided
Retention:   Samples With DNA
Description:
blood and serum for patients consenting to banking on lymphoma treatment studies
Non-Probability Sample
Patients consenting to 8947 banking of blood and serum
Lymphoma
Other: biologic sample preservation procedure
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
939
July 2011
July 2011   (Final data collection date for primary outcome measure)

DISEASE CHARACTERISTICS:

  • Diagnosis of non-Hodgkin lymphoma

    • Previously untreated disease
    • Patients must meet the eligibility criteria and be registered to a currently active Southwest Oncology Group-coordinated treatment protocol for previously untreated non-Hodgkin lymphoma

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • See Disease Characteristics
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01000558
CDR0000390329
SWOG-8947 ( Other Identifier: SWOG )
U10CA032102 ( U.S. NIH Grant/Contract )
No
Not Provided
Not Provided
Southwest Oncology Group
Southwest Oncology Group
National Cancer Institute (NCI)
Study Chair: Richard I. Fisher, MD James P. Wilmot Cancer Center
Southwest Oncology Group
May 2013